Dementia poses a growing challenge for health services but remains stigmatized and under‐
recognized. Digital technologies to aid the earlier detection of dementia are approaching …

Alpha-synucleinopathies can be identified in their prodromal phase, raising several ethical
issues. In this review, we first provide definitions of prodromal α-synucleinopathies and …

Abstract Mild Cognitive Impairment (MCI) is a diagnostic category indicating cognitive
impairment which does not meet diagnostic criteria for dementia such as Alzheimer's …

Background Evidence on potentially modifiable risk factors for dementia is accumulating
rapidly, including eg physical inactivity, hypertension, or diabetes. It is unclear to what extent …

Background Well-established electronic data capture in UK general practice means that
algorithms, developed on patient data, can be used for automated clinical decision support …

Background and purpose Careful counseling through the diagnostic process and adequate
postdiagnostic support in patients with mild cognitive impairment (MCI) is important …

Objectives UK statistics suggest only two-thirds of patients with dementia get a diagnosis
recorded in primary care. General practitioners (GPs) report barriers to formally diagnosing …

Background: The focus on early detection of dementia and Mild Cognitive Impairment (MCI)
diagnosis has entered the clinics' daily routine. However, there exist epistemic uncertainty …

Introduction We conducted a systematic literature review and meta‐analysis of empirical
evidence on expected and experienced implications of sharing Alzheimer's disease (AD) …

Biomarker-based predictive tests for subjectively asymptomatic Alzheimer's disease (AD)
are utilized in research today. Novel applications of artificial intelligence (AI) promise to …